D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 47 Citations 6,579 133 World Ranking 3727 National Ranking 1471

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Antibiotic resistance
  • Staphylococcus aureus

Paul R. Rhomberg mainly focuses on Microbiology, Ceftazidime, Meropenem, Antibiotic resistance and Cefepime. His Enterobacteriaceae research extends to the thematically linked field of Microbiology. His Ceftazidime research focuses on Cephalosporin and how it connects with Cefpirome, Salmonella, Ceftolozane, Bacteroides fragilis and Piperacillin/tazobactam.

His research in Antibiotic resistance intersects with topics in Penicillin, Ciprofloxacin, Group B Streptococcal Infection and Drug resistance. His studies in Cefepime integrate themes in fields like Piperacillin and Tazobactam. His Antibacterial agent research is multidisciplinary, incorporating perspectives in Moxifloxacin, Daptomycin and Streptococcus pneumoniae.

His most cited work include:

  • Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995 (493 citations)
  • Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008). (140 citations)
  • Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995 (127 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Microbiology, Broth microdilution, Antimicrobial, Staphylococcus aureus and Meropenem. His research related to Antibacterial agent, Carbapenem, Streptococcus pneumoniae, Tazobactam and Imipenem might be considered part of Microbiology. His Streptococcus pneumoniae research focuses on Haemophilus influenzae and how it relates to Virology.

His Broth microdilution research also works with subjects such as

  • Pseudomonas aeruginosa, which have a strong connection to Polymyxin B and Acinetobacter,
  • Klebsiella pneumoniae which intersects with area such as Enterobacteriaceae. His Antimicrobial study integrates concerns from other disciplines, such as Antibiotics and Antibiotic resistance. His study looks at the intersection of Meropenem and topics like Ciprofloxacin with Moxifloxacin.

He most often published in these fields:

  • Microbiology (88.03%)
  • Broth microdilution (30.28%)
  • Antimicrobial (21.13%)

What were the highlights of his more recent work (between 2018-2021)?

  • Microbiology (88.03%)
  • Broth microdilution (30.28%)
  • Antimicrobial (21.13%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Microbiology, Broth microdilution, Antimicrobial, Sentry and Klebsiella pneumoniae. His study in Microbiology is interdisciplinary in nature, drawing from both Gram, Tedizolid and Staphylococcus aureus. He has researched Broth microdilution in several fields, including Enterobacterales and Colistin.

The Antimicrobial study combines topics in areas such as Pseudomonas aeruginosa and Tebipenem. Paul R. Rhomberg interconnects Long acting, Antifungal, Clinical trial and Echinocandin in the investigation of issues within Sentry. The study incorporates disciplines such as Carbapenem, Meropenem, Imipenem, Proteus mirabilis and Enterobacteriaceae in addition to Klebsiella pneumoniae.

Between 2018 and 2021, his most popular works were:

  • Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination. (13 citations)
  • Evaluation of the Bactericidal Activity of Fosfomycin in Combination with Selected Antimicrobial Comparison Agents Tested against Gram-Negative Bacterial Strains by Using Time-Kill Curves. (11 citations)
  • Activity of fosfomycin when tested against US contemporary bacterial isolates. (9 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Staphylococcus aureus
  • Antibiotic resistance

His scientific interests lie mostly in Microbiology, Staphylococcus aureus, Fosfomycin, Candida glabrata and Candida tropicalis. Many of his studies involve connections with topics such as Klebsiella pneumoniae and Microbiology. His Klebsiella pneumoniae research incorporates themes from Pseudomonas aeruginosa, Broth microdilution, Enterobacteriaceae and Acinetobacter.

His Candida glabrata study incorporates themes from Candida parapsilosis, Candida dubliniensis and Candida krusei. His study in Clindamycin is interdisciplinary in nature, drawing from both Methicillin-resistant Staphylococcus aureus and Tedizolid. Paul R. Rhomberg has researched Resistant bacteria in several fields, including Enterobacterales and Sentry.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Antimicrobial Resistance among Clinical Isolates of Streptococcus pneumoniae in the United States during 1999–2000, Including a Comparison of Resistance Rates since 1994–1995

Gary V. Doern;Kristopher P. Heilmann;Holly K. Huynh;Paul R. Rhomberg.
Antimicrobial Agents and Chemotherapy (2001)

773 Citations

Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008).

Paul R. Rhomberg;Ronald N. Jones.
Diagnostic Microbiology and Infectious Disease (2009)

228 Citations

Fluoroquinolone Resistance in Streptococcus pneumoniae in United States since 1994-1995

Angela B. Brueggemann;Stacy L. Coffman;Paul Rhomberg;Holly Huynh.
Antimicrobial Agents and Chemotherapy (2002)

196 Citations

Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).

Lalitagauri M. Deshpande;Paul R. Rhomberg;Helio S. Sader;Ronald N. Jones.
Diagnostic Microbiology and Infectious Disease (2006)

183 Citations

Antimicrobial Activity of CXA-101, a Novel Cephalosporin Tested in Combination with Tazobactam against Enterobacteriaceae, Pseudomonas aeruginosa, and Bacteroides fragilis Strains Having Various Resistance Phenotypes

Helio S. Sader;Paul R. Rhomberg;David J. Farrell;Ronald N. Jones.
Antimicrobial Agents and Chemotherapy (2011)

177 Citations

In vitro antimicrobial activity of S-649266, a catechol-substituted siderophore cephalosporin, when tested against non-fermenting Gram-negative bacteria

Akinobu Ito;Naoki Kohira;Samuel K. Bouchillon;Joshua West.
Journal of Antimicrobial Chemotherapy (2016)

169 Citations

Group B streptococci causing neonatal bloodstream infection: antimicrobial susceptibility and serotyping results from SENTRY centers in the Western Hemisphere.

Janet I. Andrews;Daniel J. Diekema;Stephen K. Hunter;Paul R. Rhomberg.
American Journal of Obstetrics and Gynecology (2000)

168 Citations

Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999–2001)

Alan H. Mutnick;Paul R. Rhomberg;Helio S. Sader;Ronald N. Jones.
Journal of Antimicrobial Chemotherapy (2004)

146 Citations

Effect of the β-Lactamase Inhibitor Vaborbactam Combined with Meropenem against Serine Carbapenemase-Producing Enterobacteriaceae

Mariana Castanheira;Paul R. Rhomberg;Robert K. Flamm;Ronald N. Jones.
Antimicrobial Agents and Chemotherapy (2016)

141 Citations

Antifungal susceptibility patterns of a global collection of fungal isolates: results of the SENTRY Antifungal Surveillance Program (2013).

Mariana Castanheira;Shawn A. Messer;Paul R. Rhomberg;Michael A. Pfaller.
Diagnostic Microbiology and Infectious Disease (2016)

139 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Paul R. Rhomberg

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 86

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 81

Robert K. Flamm

Robert K. Flamm

Janssen (Belgium)

Publications: 57

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 54

George G. Zhanel

George G. Zhanel

University of Manitoba

Publications: 49

James A. Karlowsky

James A. Karlowsky

University of Manitoba

Publications: 44

Mariana Castanheira

Mariana Castanheira

JMI Laboratories

Publications: 42

Matteo Bassetti

Matteo Bassetti

University of Genoa

Publications: 37

Michael J. Rybak

Michael J. Rybak

Wayne State University

Publications: 34

Daryl J. Hoban

Daryl J. Hoban

University of Manitoba

Publications: 33

Jason A. Roberts

Jason A. Roberts

University of Queensland

Publications: 31

Rodrigo E. Mendes

Rodrigo E. Mendes

JMI Laboratories

Publications: 29

Maiken Cavling Arendrup

Maiken Cavling Arendrup

Statens Serum Institut

Publications: 29

David L. Paterson

David L. Paterson

University of Queensland

Publications: 27

Robert A. Bonomo

Robert A. Bonomo

Case Western Reserve University

Publications: 26

David R. Andes

David R. Andes

University of Wisconsin–Madison

Publications: 25

Trending Scientists

Stephen Clark

Stephen Clark

Cambridge Quantum Computing

Myung-Han Yoon

Myung-Han Yoon

Gwangju Institute of Science and Technology

Riccardo Casalini

Riccardo Casalini

United States Naval Research Laboratory

Ruben Kretzschmar

Ruben Kretzschmar

ETH Zurich

Miguel Ángel Centeno

Miguel Ángel Centeno

Spanish National Research Council

Michael Giersig

Michael Giersig

Japanese Society for Artificial Intelligence

Daniel C. Laughlin

Daniel C. Laughlin

University of Wyoming

Giuliana Parisi

Giuliana Parisi

University of Florence

Jeffrey S. Rubin

Jeffrey S. Rubin

National Institutes of Health

Barbara Sollner-Webb

Barbara Sollner-Webb

Johns Hopkins University School of Medicine

Claus U. Hammer

Claus U. Hammer

University of Copenhagen

Jacobus M. Verstraten

Jacobus M. Verstraten

University of Amsterdam

Marie Johnston

Marie Johnston

University of Aberdeen

B. F. Skinner

B. F. Skinner

Harvard University

Eiichi Tahara

Eiichi Tahara

Hiroshima University

Something went wrong. Please try again later.